Prenetics: Scientific Advisory Board
Prenetics has formed a scientific advisory board made up of Tony Mok, Pasi Jänne, Pan-Chyr Yang, Hua-Chien Chen, Frank Ong, and Lawrence Tzang.
Mok will lead the board and is currently chairman of the department of clinical oncology of Chinese University of Hong Kong. He is also a non-executive director of AstraZeneca and an independent director of Hutchmed.
Jänne is a thoracic medical oncologist at the Dana Farber Cancer Institute and professor of medicine at Harvard Medical School. He is also the director of the Lowe Center for Thoracic Oncology and the director of the Belfer Center for Applied Cancer Science, both at Dana Farber.
Yang is a professor in the department of internal medicine at National Taiwan University's College of Medicine and dean of the college. He was previously president of the university and has also served as the director of the Advisory Office for the Ministry of Education.
Chen is the cofounder and CSO of cancer genomics firm ACT Genomics. He was previously associate professor at Chang Gung University and an assistant investigator at the National Health Research Institute. Chen also served as biology director at pharmaceutical company TaiGen Biotechnology.
Ong is Prenetics' chied medical officer and interim CEO of ACT Genomics. Before Prenetics, he was CMO and CSO of Everly Health and he has previously held leadership roles at Guardant Health, Illumina, and Roche.
Tzang is cofounder and CSO of Prenetics. He is a founding member and former secretary of the Hong Kong Society for Behavioural and Neural Genetics and a fellow of the Hong Kong Society for Molecular Diagnostic Sciences.